M. Heinrich

Patient Reported Outcome (PRO) Among High-Grade Glioma Patients Receiving TTFields Treatment: A Two Center Observational Study

U. Goerling, P. Vajkoczy, D. Krex, 2019, Front. Neurol..

CML-466 Asciminib Provides Durable Molecular Responses in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With the T315I Mutation: Updated Efficacy and Safety Data From a Phase I Trial.

M. Talpaz, M. Mauro, A. Hochhaus, 2022, Clinical lymphoma, myeloma & leukemia.

VOYAGER: an open-label, randomised, phase 3 study of avapritinib vs regorafenib in patients with locally advanced metastatic or unresectable gastrointestinal stromal tumour.

W. Tap, R. Jones, S. Bauer, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

VOYAGER: An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST).

W. Tap, S. George, S. Bauer, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.